Copyright Reports & Markets. All rights reserved.

Global Hemophilia Drugs Market Data Survey Report 2013-2025

Buy now

Table of Contents

    1 Global Market Overview

    • 1.1 Scope of Statistics
      • 1.1.1 Scope of Products
      • 1.1.2 Scope of Manufacturers
      • 1.1.3 Scope of Application
      • 1.1.4 Scope of Type
      • 1.1.5 Scope of Regions/Countries
    • 1.2 Global Market Size

    2 Regional Market

    • 2.1 Regional Production
    • 2.2 Regional Demand
    • 2.3 Regional Trade

    3 Key Manufacturers

    • 3.1 Baxalta
      • 3.1.1 Company Information
      • 3.1.2 Product & Services
      • 3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.1.4 Recent Development
    • 3.2 Bayer
      • 3.2.1 Company Information
      • 3.2.2 Product & Services
      • 3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.2.4 Recent Development
    • 3.3 CSL Behring
      • 3.3.1 Company Information
      • 3.3.2 Product & Services
      • 3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.3.4 Recent Development
    • 3.4 Novo Nordisk
      • 3.4.1 Company Information
      • 3.4.2 Product & Services
      • 3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.4.4 Recent Development
    • 3.5 Pfizer
      • 3.5.1 Company Information
      • 3.5.2 Product & Services
      • 3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.5.4 Recent Development
    • 3.6 Roche
      • 3.6.1 Company Information
      • 3.6.2 Product & Services
      • 3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.6.4 Recent Development
    • 3.7 Alnylam Pharmaceuticals
      • 3.7.1 Company Information
      • 3.7.2 Product & Services
      • 3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.7.4 Recent Development
    • 3.8 Amarna Therapeutics
      • 3.8.1 Company Information
      • 3.8.2 Product & Services
      • 3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.8.4 Recent Development
    • 3.9 Asklepios BioPharmaceutical
      • 3.9.1 Company Information
      • 3.9.2 Product & Services
      • 3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.9.4 Recent Development
    • 3.10 Biogen
      • 3.10.1 Company Information
      • 3.10.2 Product & Services
      • 3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.10.4 Recent Development
    • 3.11 BioMarin
      • 3.11.1 Company Information
      • 3.11.2 Product & Services
      • 3.11.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.11.4 Recent Development
    • 3.12 Catalyst Bioscience
      • 3.12.1 Company Information
      • 3.12.2 Product & Services
      • 3.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.12.4 Recent Development
    • 3.13 Chiesi Farmaceutici
      • 3.13.1 Company Information
      • 3.13.2 Product & Services
      • 3.13.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.13.4 Recent Development
    • 3.14 Dimension Therapeutics
      • 3.14.1 Company Information
      • 3.14.2 Product & Services
      • 3.14.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.14.4 Recent Development
    • 3.15 Emergent BioSolutions
      • 3.15.1 Company Information
      • 3.15.2 Product & Services
      • 3.15.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.15.4 Recent Development
    • 3.16 Grifols, Kedrion Biopharma
      • 3.16.1 Company Information
      • 3.16.2 Product & Services
      • 3.16.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.16.4 Recent Development
    • 3.17 Octapharma
      • 3.17.1 Company Information
      • 3.17.2 Product & Services
      • 3.17.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.17.4 Recent Development
    • 3.18 rEVO Biologics
      • 3.18.1 Company Information
      • 3.18.2 Product & Services
      • 3.18.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.18.4 Recent Development
    • 3.19 OPKO Biologics
      • 3.19.1 Company Information
      • 3.19.2 Product & Services
      • 3.19.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.19.4 Recent Development
    • 3.20 Sangamo Biosciences
      • 3.20.1 Company Information
      • 3.20.2 Product & Services
      • 3.20.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.20.4 Recent Development
    • 3.21 Spark Therapeutics
      • 3.21.1 Company Information
      • 3.21.2 Product & Services
      • 3.21.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 3.22 Swedish Orphan Biovitrum
      • 3.22.1 Company Information
      • 3.22.2 Product & Services
      • 3.22.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

    4 Major Application

    • 4.1 Clinic
      • 4.1.1 Overview
      • 4.1.2 Clinic Market Size and Forecast
    • 4.2 Hospital
      • 4.2.1 Overview
      • 4.2.2 Hospital Market Size and Forecast

    5 Market by Type

      5.By Hemophilia A

      • 5.1 Hemophilia A
        • 5.1.1 Overview
        • 5.1.2 Hemophilia A Market Size and Forecast
      • 5.2 Hemophilia B
        • 5.2.1 Overview
        • 5.2.2 Hemophilia B Market Size and Forecast
      • 5.3 Hemophilia C
        • 5.3.1 Overview
        • 5.3.2 Hemophilia C Market Size and Forecast

      6 Price Overview

      • 6.1 Price by Manufacturers
      • 6.2 Price by Application
      • 6.3 Price by Type

      7 Conclusion

      Summary
      The global Hemophilia Drugs market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:
      Global market size and forecast
      Regional market size, production data and export & import
      Key manufacturers profile, products & services, sales data of business
      Global market size by Major Application
      Global market size by Major Type
      Key manufacturers are included based on company profile, sales data and product specifications etc.:
      Baxalta 
      Bayer 
      CSL Behring 
      Novo Nordisk 
      Pfizer 
      Roche 
      Alnylam Pharmaceuticals 
      Amarna Therapeutics 
      Asklepios BioPharmaceutical 
      Biogen 
      BioMarin 
      Catalyst Bioscience 
      Chiesi Farmaceutici 
      Dimension Therapeutics 
      Emergent BioSolutions 
      Grifols, Kedrion Biopharma 
      Octapharma 
      rEVO Biologics 
      OPKO Biologics 
      Sangamo Biosciences 
      Spark Therapeutics 
      Swedish Orphan Biovitrum
      Major applications as follows:
      Clinic 
      Hospital
      Major Type as follows:
      Hemophilia A 
      Hemophilia B 
      Hemophilia C
      Regional market size, production data and export & import:
      Asia-Pacific
      North America
      Europe
      South America
      Middle East & Africa

      Buy now